Showing 341 - 360 results of 404 for search 'presented left ventricular function', query time: 0.14s Refine Results
  1. 341

    Cardiovascular remodeling in patients with diabetic сardiomyopathy by A. S. Veklich, N. A. Koziolova, P. G. Karavaev

    Published 2019-11-01
    “…Among outpatients with newly diagnosed type 2 diabetes (T2D), according  to inclusion and exclusion criteria, a group of participants  with diabetic cardiomyopathy (DCM) with left ventricular diastolic dysfunction (LV DD) was made before treatment. …”
    Get full text
    Article
  2. 342

    Contrast-induced nephropathy in patients with acute coronary syndrome with ST-segment elevation: risk factors and prognosis by O. V. Arsenicheva, N. N. Shchapovа

    Published 2020-01-01
    “…Killip III–IV (90 %) were significantly more often observed. The left ventricular ejection fraction was lower in patients with СIN (p <0.05). …”
    Get full text
    Article
  3. 343

    Impact of Phosphodiesterase-3 Inhibitor and Prostacyclin Analogue Combination on Pulmonary Hemodynamics in Acyanotic Congenital Heart Disease Patients with Pulmonary Hypertension:... by Sefri Noventi Sofia, Bahrudin, Ignatius Riwanto, Anindita Soetadji, Hardhono, Muhammad Thifan Satyagraha

    Published 2025-06-01
    “…Background: Acyanotic congenital heart disease (ACHD) with left-to-right shunting frequently presents with pulmonary hypertension (PH), especially in developing countries where treatment options are often limited and costly. …”
    Get full text
    Article
  4. 344

    Epidemiological Profile of Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome in a Single Tertiary Center in Basrah, Iraq by Ola Murtadaa Albattat, Raheem Sharhan Balasim, Ammar Saleh Abbood, Warkaa Shamkhani

    Published 2025-06-01
    “…Data from 388 ACS patients aged ≥18 years were analyzed, focusing on demographics, comorbidities, and clinical presentations. Variables included age, sex, BMI, smoking history, medical history and left ventricular function. …”
    Get full text
    Article
  5. 345

    Treating Congenital Diaphragmatic Hernia with ECMO: First Successful Case in Romania by Alina Elena GAIDUCHEVICI, Carmina GEORGESCU, Carmen Mariana HERISEANU, Ana Mihaela BIZUBAC, Cristina FILIP, Irina MARGARINT, Ion CERNEA, Catalin Gabriel CIRSTOVEANU

    Published 2021-09-01
    “…Curie” Emergency Clinical Hospital for Children, Newborn Intensive Care Unit: a term neonate with cardiorespiratory failure secondary to left sided congenital diaphragmatic hernia. The patient was placed on veno-venous ECMO at three days of life; however, on the fourth day, due to unstable right ventricular function, conversion to veno-arterial ECMO was mandatory. …”
    Get full text
    Article
  6. 346

    New possibilities of nephroprotection in patients with chronic heart failure in combination with chronic kidney disease and diabetes mellitus 2 or without it by E. V. Kovalenko, L. I. Markova, O. L. Belaya

    Published 2022-10-01
    “…Representatives from this group demonstrated cardiovascular safety and high efficacy in patients with chronic heart failure, both with reduced (EMPEROR reduced, DAPA-HF studies) and preserved left ventricular ejection fraction (EMPEROR-Preserved, DELIVER studies), regardless of the presence of sugar diabetes. …”
    Get full text
    Article
  7. 347

    Cathepsin-D and outcomes in peripartum cardiomyopathy: Results from IPAC by Vincenzo B. Polsinelli, Karen Hanley-Yanez, Charles F. McTiernan, Kalgi Modi, Jennifer Haythe, Hal Skopicki, Uri Elkayam, Leslie T. Cooper, Jr, James D. Fett, Dennis M. McNamara

    Published 2025-01-01
    “…Survival free from major cardiovascular events (death, transplantation, or left ventricular assist device) was determined up to 12 months post-partum (PP). …”
    Get full text
    Article
  8. 348

    Characteristics of patients with chronic heart failure with mildly reduced ejection fraction: clinical and demographic aspect by M. T. Duishenalieva, A. G. Polupanov, F. T. Rysmatova, E. Zh. Myrzabekova, N. E. Esenbekova, N. Ch. Cholponbekova, E. Sh. Altymyshova, A. T. Arykova, N. B. Cheskidova, E. D. Djyshambaev

    Published 2025-05-01
    “…A new class of chronic heart failure (CHF) has been identified recently – heart failure with mildly reduced left ventricular ejection fraction (HFmrEF). The determinants and outcomes of this phenotype are still being clarified.The aim. …”
    Get full text
    Article
  9. 349

    Sex Differences in Outcomes of Adults with Repaired Coarctation of Aorta and Concomitant Aortic Valve Disease by Alexander C. Egbe, MD, MPH, Barry A. Borlaug, MD, William R. Miranda, MD, Snigdha Karnakoti, MBBS, Ahmed E. Ali, MBBS, Ahmed Younis, MBBS, Heidi M. Connolly, MD

    Published 2024-11-01
    “…Methods: A retrospective study was conducted of adults with repaired coarctation of aorta and ≥ moderate aortic stenosis and/or aortic regurgitation. Cardiac remodelling (left ventricular [LV], left atrial, right ventricular [RV], and right atrial structure and function) and symptomatic and/or functional class were determined at the baseline encounter. …”
    Get full text
    Article
  10. 350

    Large Variations in Phenylalanine Concentrations Associate Adverse Cardiac Remodelling in Adult Patients With Phenylketonuria—A Long‐Term CMR Study by Radu Tanacli, Patrick Doeblin, Alessandro Faragli, Jan‐Hendrik Hassel, Christian Stehning, Ursula Plöckinger, Athanasia Ziagaki, Sebastian Kelle

    Published 2025-02-01
    “…The CMR protocol included left (LV) and right (RV) ventricular and left atrial (LA) volumetric assessment, LV parametric mapping (precontrast and postcontrast T1 and T2 maps, extracellular volume [ECV]), multilayer LV myocardial strain, systolic and diastolic hemodynamic forces and RV and LA strain and aortic distensibility evaluation. …”
    Get full text
    Article
  11. 351

    IGFBP5 mediates the therapeutic effect of isoliquiritigenin in myocardial ischemia-reperfusion injury via AKT/GLUT4 regulated insulin resistance by Jue Bai, Jue Bai, Si-Yuan Yang, Shao-Mei Yu, Ying Cao, Chang-Han Ma, Chang-Han Ma, Xuan-Yi Hu, Xiong Chen, Ying-Nan Song, Ying-Nan Song, Hong-Jin Chen, Hong-Jin Chen, Hong-Jin Chen

    Published 2025-04-01
    “…Finally, lentivirus were used to silence or over-express IGFBP5 to elucidate the role of IGFBP5 in regulating the therapeutic effects of ISL on IR in MIRI.ResultsIn the present study, In vivo experiments demonstrated that ISL attenuated myocardial infarct size, decreased serum markers of myocardial injury, improved left ventricular systolic function, and enhanced insulin sensitivity. …”
    Get full text
    Article
  12. 352

    Exercise Hemodynamics and Mitochondrial Oxidative Capacity in Disease Stages of Wild‐Type Transthyretin Amyloid Cardiomyopathy by Bertil Ladefoged, Anders Dahl Pedersen, Jacob Seefeldt, Bent Roni Ranghøj Nielsen, Hans Eiskjær, Emil Lichscheidt, Tor Clemmensen, Julian David Gillmore, Steen Hvitfeldt Poulsen

    Published 2024-07-01
    “…Patients with ATTRwt had a reduced oxidative phosphorylation capacity which correlated to left ventricular mass but not to cardiac output capacity. …”
    Get full text
    Article
  13. 353

    THE FIRST EXPERIENCE OF MULTICOMPONENT PLASTIC MK WITH STRENGTHENING OF THE ANNULUS WITH VASCULAR PROSTHESIS by E. A. Rizayev, F. F. Turaev

    Published 2019-06-01
    “…However, valve prosthesis, on the one hand, solves the problem of mitral defect recurrence, on the other hand, it determines the risk of left ventricular (LV) remodeling with impairment of its function. …”
    Get full text
    Article
  14. 354

    ECMO‐Assisted Da Vinci Robotic Surgery for Pheochromocytoma‐Induced Acute Catecholamine Cardiomyopathy: A Case Report by Qi Wang, Jiayan Xin, Xiaoqiong Cui, Liya Hu, Meng Ning, Wenqing Gao, Yingwu Liu

    Published 2025-08-01
    “…A 40‐year‐old female patient presented with a 6‐day history of an adrenal mass, labile hypertension range of 180–120/80–90 mmHg, hyperglycemia at 19 mmol/L, and respiratory distress that progressed to cardiogenic shock with a left ventricular ejection fraction (LVEF) of 18%. …”
    Get full text
    Article
  15. 355

    Cardiac MRI of differing ischemia and reperfusion times in a myocardial infarction pig model by David Boll, Simon Reiss, Heidi R. Cristina Schmitz, Christian Weber, Julien Thielmann, Felix Spreter, Kian Tadjalli Mehr, Diana Chiang, Markus Jäckel, Lukas Heger, Jonathan Rilinger, Dirk Westermann, Constantin von zur Mühlen, Timo Heidt, Michael Bock, Alexander Maier

    Published 2025-07-01
    “…CMR revealed IRI in 14 of 15 animals in cardiac segments analogous to those supplied by the respective artery in humans. The mean left ventricular ejection fraction was reduced to 52% and 47% of animals had an impaired wall motion. …”
    Get full text
    Article
  16. 356

    High afterload rather than myocardial fibrosis predicts reduced ejection fraction in severe aortic stenosis with afterload mismatch by Anton Doubell, Philip Herbst, Megan Rian Rajah

    Published 2025-05-01
    “…Background Afterload mismatch (AM) refers to high-gradient (mean gradient ≥40 mm Hg) severe aortic stenosis (AS) with reduced left ventricular ejection fraction (LVEF <50%) that is hypothesised to arise from mechanisms other than true contractile impairment. …”
    Get full text
    Article
  17. 357

    The comparative study of the efficacy of recombinant human brain natriuretic peptide combined with vasoactive medications for elderly patients with heart failure and hypotension re... by Rui Meng, Xiangnan Li, Huimin Liu, Zhong Yi, Yalei Han, Qing Xie, Helu Xiu, Fei Yao, Na Guo, Yan Yu

    Published 2025-03-01
    “…Troponin I levels were also lower in the combination therapy groups compared to the rhBNP-alone group (P < 0.05). Left ventricular ejection fraction (LVEF) was significantly higher in the combination therapy groups compared to the rhBNP-alone group (P < 0.05). …”
    Get full text
    Article
  18. 358
  19. 359

    Device‐therapy in chronic heart failure: Cardiac contractility modulation versus cardiac resynchronization therapy by Goekhan Yuecel, Leo Gaasch, Abbass Kodeih, Svetlana Hetjens, Babak Yazdani, Stefan Pfleger, Daniel Duerschmied, William T. Abraham, Ibrahim Akin, Juergen Kuschyk

    Published 2025-02-01
    “…Abstract Aims Cardiac implantable electrical devices such as cardiac resynchronization therapy with defibrillator (CRT‐Ds) or cardiac contractility modulation (CCMs) are therapy options for patients with symptomatic heart failure (HF) and reduced left ventricular ejection fraction (LVEF) despite optimal medical treatment. …”
    Get full text
    Article
  20. 360

    The aspirin resistance and platelets` receptors expression in chronic heart failure patients with type 2 diabetes mellitus by M. Yu. Kolesnyk, V. V. Syvolap

    Published 2014-06-01
    “…Age, sex, severity of CHF, left ventricular ejection fraction (LVEF), estimated glomerular filtration rate and cardiovascular treatment were comparable between three groups. …”
    Get full text
    Article